🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A walk down memory lane 📸 First day #GIfellowship at UChicagoIBD years ago Wishing all the new #interns #residents #fellows #faculty a very happy first day! So proud of my mentees embarking on new journeys this week Lauren Loeb, MD Luis Miguel Nieto M Khaled Almujarkesh Aakash Desai, MD

Want to learn more about #GLP2 and outcomes in #IBD check our new pub roypounder.apt @akmd03

🚨 Excited to announce our new publication in the prestigious AJG - The American Journal of Gastroenterology ! We compared the effectiveness of Upadacitinib vs Tofacitinib in UC journals.lww.com/ajg/abstract/9… Thank you for your invaluable support Gursimran Kochhar MD Aakash Desai, MD Francis (Frank) Farraye, MD, MSc Vipul Jairath MBChB DPhil AHNIMres AHN Gastroenterology, Hepatology and Nutrition

#SundayRead☕️ All #JAKi are not= 🔺UPA>TOFA in UC:⬇️ IV steroids &✂️ @12mos 🚩IMO, Still a role for TOFA ✅Liquid PO form ✅Pouchitis ✅Post bowel✂️,Ostomy, severe diarrhea (some ASUC):⬇️UPA performance vs TOFA (sustained vs immediate release)-Can split UPA dose/+anti-diarrhea)

Honored to have 12 abstracts selected as first author, including 1 oral presentation, and 19+ abstracts overall at ACG 2024! 🙏 for the invaluable guidance from Gursimran Kochhar MD Aakash Desai, MD Nabeeha Mohy-ud-din MD Francis (Frank) Farraye, MD, MSc Mohammad Bilal, MD Akash Gadani AHNIMres AHN Gastroenterology, Hepatology and Nutrition

A look into the intriguing possibilities that lie at the intersection of weight loss & #IBD management. You’ll hear from gastroenterologist + researcher Aakash Desai, MD, along with 25+ people who have IBD who are taking GLP-1RA medications. #crohns #colitis lightscameracrohns.com/2024/07/29/the…

Check out our comprehensive review on 🔦 approaches to management of dysplasia in IBD published in Indian Journal of Gastroenterology Tremendous work by future 🌟 AEF @Achintya_singh4 under the mentorship of Gursimran Kochhar MD

New study: Patients with IBD at higher risk for RSV hospitalization (aOR 1.30) Key findings: ↑ risk in 18-49 & 65+ age groups IBD + CVD: 3.35x hospitalization risk Recent steroids ↑ risk (aOR 1.86) journals.lww.com/ajg/abstract/2…

What are the various endoscopic techniques to manage dysplasia in IBD❔ We summarized it for you!! 🙏🙏 Gursimran Kochhar MD Aakash Desai, MD 🔑 Role of AI in detection 🔑 ESD in IBD 🔑 Full thickness resection & More!! ↘️↘️↘️ 📜 link.springer.com/article/10.100…

The burden of #IBD is high in young #women and is increasing. Read more about #epidemiology of IBD in our recent paper, led by Karn Wijarnpreecha pubmed.ncbi.nlm.nih.gov/39068136/

💊Have you ever had a patient with #IBD who previously failed TOFA and wondered if there is opportunity to use UPA for treatment? Check out our paper from the #IBD group at Mayo Clinic Florida Gastroenterology & Hepatology Francis (Frank) Farraye, MD, MSc Jana G Hashash, MD, MSc Jami Kinnucan, MD, FACG, AGAF, FCCF Christian Karime, MD 📖 rdcu.be/dTubC

From presenting 3️⃣ posters at Western PA ACP ACP to 1️⃣1️⃣ at ACG over two back to back days, with heartfelt recognitions 🏆🎖 for our team's dedication! AHNIMres AHN Gastroenterology, Hepatology and Nutrition AHN Medicine Institute

Check out our new #publication looking at Ozanimod and Vedolizumab in patients with #ulcerativecolitis #ibd #bigdata from ⁦AHN Gastroenterology, Hepatology and Nutrition⁩ Aakash Desai, MD ⁦Himsikhar Khataniar⁩ ⁦Fjona Tabaku, MD MPH⁩ ⁦Francis (Frank) Farraye, MD, MSc⁩ ⁦Jana G Hashash, MD, MSc⁩ pubmed.ncbi.nlm.nih.gov/39478367/

Use of #EFTR in management of #dysplasia #polyps in patients with #IBD Initial experience It is still early days, but it is a good choice for carefully selected patients!! Can be organ saving pubmed.ncbi.nlm.nih.gov/?term=Kochhar+… Himsikhar Khataniar Aakash Desai, MD AHN Gastroenterology, Hepatology and Nutrition

Excited to share: Obesity assoc w worse outcomes in UC roypounder.apt Aakash Desai, MD James Lewis Gary Lichtenstein, MD Gursimran Kochhar MD Francis (Frank) Farraye, MD, MSc ✔️UC pts w/ BMI > 30 had inc risk of steroid use, change in therapy, and colectomy ✔️Seen in pts on vedo, UST, anti-TNF & JAKi pubmed.ncbi.nlm.nih.gov/39844347/

Great collaboration between MilestoneIBD alumni Priya Sehgal MD MS MPH Thank you to roypounder.apt for publishing our work! Gursimran Kochhar MD Francis (Frank) Farraye, MD, MSc Himsikhar Khataniar AHN Gastroenterology, Hepatology and Nutrition

We are honored to receive this award from IBDJournal & CC360 and Crohn's & Colitis Foundation! Incredibly fortunate to have Gursimran Kochhar MD as a mentor. Thank you to all the co-authors for their support and expertise Francis (Frank) Farraye, MD, MSc Jana G Hashash, MD, MSc Miguel Regueiro

Less than a month left for the AHN Gastroenterology, Hepatology and Nutrition GI and Liver Conference 4/5/2025 Fairmont in Pittsburgh, PA Registration FREE (except physicians $50): cme.ahn.org Join the conversation with experts from around the country helping us take better care of our patients ⭐️

Join us NEXT Saturday at the BEST conference (I’m biased 😆)as we learn from Elliot Tapper Mazen Noureddin, MD, MHSc Jessica Davis Shifa Umar, MD Jasmohan Bajaj & a full ⭐️ line up The talks will be great The food will be delicious The weather we will 🤲🏻 for Register: cme.ahn.org

Not all patients with #UC may need biological therapy but how do we know which ones do and how we counsel our #patients on natural history of #UC Check out our paper to learn more about #naturalhistory of UC pubmed.ncbi.nlm.nih.gov/40554593/ Aakash Desai, MD Himsikhar Khataniar